Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier. Puchongmart C, Rodriguez CC, Soliman D, Shotelersuk V, et al. J Cardiovasc Pharmacol 2026 Jul 6. doi: 10.1097/FJC.0000000000001855.

Read + Share

Amedeo Smart

Independent Medical Education

Puchongmart C, Rodriguez CC, Soliman D, Shotelersuk V, et al. Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier. J Cardiovasc Pharmacol 2026 Jul 6. doi: 10.1097/FJC.0000000000001855.
PMID: 42467942